{
  "docId": "019de074-753e-742e-8482-2e45ed67d022",
  "docSlug": "1014e5ae1361495c3b249a754ba0dfae",
  "documentTitle": "argenx SE | Investor Presentation Deck | 22 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 16,
  "pageCount": 22,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "other",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide illustrates the neuromuscular junction mechanism and the clinical trial progression from healthy volunteers to patients with CMS and MuSK MG.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de074-753e-742e-8482-2e45ed67d022/16",
  "deckHref": "/decks/019de074-753e-742e-8482-2e45ed67d022",
  "deckJsonHref": "/decks/019de074-753e-742e-8482-2e45ed67d022.json",
  "deckAnchorHref": "/decks/019de074-753e-742e-8482-2e45ed67d022#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.28,
        "w": 0.15,
        "x": 0.825,
        "y": 0.015
      },
      "kind": "callout",
      "text": "clinical Broaden immunology pipeline",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c58c6206-db4d-4373-b9de-0331cf5146e6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.5,
        "x": 0.3,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Phase 1 study design showing Single Ascending Dose and Multiple Ascending Dose cohorts",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "64644b7a-f0e0-4d79-acf1-23ef4c42dc16",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.28,
        "x": 0.02,
        "y": 0.285
      },
      "kind": "image",
      "text": "Mechanism of action diagram showing motor neuron, LRP4, MuSK, and AChR",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "66e2b32c-3807-4ff9-a59d-ffcee95c9171",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.6,
        "x": 0.2,
        "y": 0.8
      },
      "kind": "paragraph",
      "text": "First-in-patient trial in CMS and MuSK MG to serve as proof of biology. Translational work ongoing in amyotrophic lateral sclerosis",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c2f4a6cf-3dc0-4e7d-b6a3-d82b5708588f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.6,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "ARGX-119: MuSK Agonist with Broad Potential in Neuromuscular Disease",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "54385b2f-bf4a-4b30-9dd8-71cea4e89143",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "AIDA Model",
      "slug": "aida-model",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "3ee37c75-201c-4fcf-bb8f-69e175d60bca",
      "evidence": "ARGX-119: MuSK Agonist with Broad Potential in Neuromuscular Disease",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 17,
      "from": 10,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "7e79228a-9d20-4cb5-bd69-2e79252b8cfc",
      "evidence": "The presentation presents the company's solution and pipeline.",
      "position": 1,
      "objective": "The company's solution and pipeline as a big bet for growth",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}